WEEKLY SURVEILLANCE
09.09.2021
SAFETY SURVEILLANCE DETAILS
TTS (Clots with low platelets)
133 cases (1 / 50,000 initial doses)
8 fatalities (5% case fatal)
Since last week’s report, a further 6 reports of blood clots and low blood platelets have been assessed as confirmed or probable TTS likely to be linked to the first dose of Vaxzevria (AstraZeneca).
Status of TTS
Myocarditis / Pericarditis*
DAEN Total: 251 Cases (up to 16)
TGA Total: 235 Cases (up to 22 Aug)*
PERICARDITIS OR MYOCARDITIS
370 Cases - 1 Death *
1 in 29,189 doses
*Variance in case numbers is likely due to the fact that people may be diagnosed with both myocarditis and pericarditis
Guillain-Barre Syndrome
110 cases (1 in 97k doses)
Immune Thrombocytopenia (ITP)
66 cases (1 in 154.6k doses)
AUSTRALIA COVID-19 VACCINE ROLLOUT DATA
09 Sept, 2021
AGED CARE COVID-19 VACCINATION RATES MAP
Updated 5pm daily
VACCINE HESITANCY MONITORING
Operation COVID Shield COVID-19 Vaccine Sentiment Summary
AusVax Safety Surveillance
AusVaxSafety will now be updating the Pfizer and AstraZeneca COVID-19 vaccine safety data on a monthly basis, instead of weekly, on this page. The next update will occur on Wednesday 15 September 2021.
MODERNA 'SPIKEVAX' APPROVED BY THE TGA
CLICK HERE to access the Australian Public Assessment Report
CYTOMEGALOVIRUS DNA IN THE ASTRAZENECA & J&J VACCINES
THE CHOICE IS YOURS
